News | Breast Imaging | July 31, 2018

Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

Deal broadens Hologic's Breast Health product portfolio and expands company's role in breast healthcare

Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

July 31, 2018 — Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital specimen radiography, for approximately $85 million.

The transaction, which closed July 31, broadens Hologic's Breast Health product portfolio and expands the company's role in the clinical continuum of care for breast cancer patients.  Specifically, Faxitron's products and channel will enable Hologic to play a larger role in breast conserving surgery, an adjacent growth market for the company's interventional breast business.

Faxitron markets a broad portfolio of products across major categories including digital specimen radiography, breast lesion localization and sentinel lymph node biopsy. The company sells its products mainly to breast surgeons and pathologists. Faxitron most recently introduced  VisionCT, what it calls the world's first 3-D breast specimen-designated computed tomography (CT) system to offer 360-degree images of excised lesions.

Faxitron generated approximately $27 million of revenue in their last fiscal year. The acquisition is expected to be roughly neutral to Hologic's non-GAAP earnings per share for the remainder of fiscal 2018 and fiscal 2019, and is expected to be accretive thereafter.

For more information: www.hologic.com

Related Content

Nanox secures $26M supported by strategic investment from Foxconn, unveiling the Startek-inspired AI Biobed for early detection
News | X-Ray | January 16, 2020
January 16, 2020 — Nanox, an innovative medical imaging techn
Carestream’s X-ray digital tomosynthesis functionality creates three-dimensional datasets from digital radiography (DR) that can be scrolled through similar to computed tomography (CT) imaging. It received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2020. Digital tomosynthesis uses a single sweep of X-ray exposures and streamlines operator workflow by separating the process of DT exposure acquisition from image volume formation.
News | Digital Radiography (DR) | January 15, 2020
January 15, 2020 — Carestream’s X-ray digital tomosynthesis (DT) functionality, which creates three-dimensional datas
Videos | RSNA | January 13, 2020
ITN Editor Dave Fornell takes a tour of some of the most innovative new medical imaging technologies displayed on the
The study found that DBN laws helped some women understand they had increased breast density, but not that breast density is associated with a higher risk of breast cancer or that dense breasts limit the ability of mammograms to detect cancer
News | Breast Density | January 09, 2020
January 9, 2020 — A new study suggests that state-mandated notifications on...
Sponsored Content | Videos | Digital Radiography (DR) | January 06, 2020
An experienced technologist and two Agfa executives talk about what distinguishes the new Agfa 100s.
Sponsored Content | Videos | Computed Tomography (CT) | January 06, 2020
Hitachi announced the FDA clearance of its newest CT – Scenaria View – at RSNA2019.
Sponsored Content | Videos | Digital Radiography (DR) | January 03, 2020
At RSNA19, David Widmann, president and CEO of Konica Minolta Healthcare Americas, discussed innovation, stressing th